Structure-activity relationships of quaternary protoberberine alkaloids having an antimalarial activity
摘要:
Seventeen quaternary protoberberine alkaloids related to berberine I were tested for antimalarial activity in vitro against Plasmodium falciparum and structure-activity relationships are proposed. The activity of the protoberberine alkaloids was influenced by the type of the oxygen substituents on rings A, C and D and the position of the oxygen functions on ring D. The position of the oxygen functions on ring D and the type of the oxygen substituents at the C-13 position (ring C) strongly influenced the activity. Shifting the oxygen functions at C-9 and C-10 to C-10 and C-Il on ring D resulted in a significant increase in the activity. Compounds bearing a methylenedioxy function at C-2 and C-3 (ring A) or C-9 and C-IO (ring D) showed higher activity than those which have methoxy groups at the same positions. Introduction of a methoxy group into the C-l position (ring A) decreased the activity. Replacement of a hydroxy group at C-2 or C-3 (ring A) by a methoxy group led to a reduction in the activity. Displacement of a hydroxy function at C-13 (ring C) by the oxygen substituents such as OMe, Oft, OCOOEt, and OCON(Me)(2) reduced the activity. In the same replacement at C-9 (ring D), the activity depended upon the type of the oxygen function. Six protoberberines displayed more potent activity than berberine 1. The activity decreased in the order: 10, 11, 17 and 18 > 7 and 8 > 1. (C) 1999 Editions scientifiques et medicales Elsevier SAS.
13,13a-DIHYDROBERBERINE DERIVATIVES, THEIR PHARMACEUTICAL COMPOSITION AND USE
申请人:Shanghai Institute of Materia Medica,
Chinese Academy of Sciences
公开号:EP2070926A1
公开(公告)日:2009-06-17
The present invention provides 13,13a-dihydroberberine derivatives or their physiologically acceptable salts represented by the following formula, pharmaceutical compositions comprising the same, and uses thereof. The 13,13a-dihydroberberine derivatives have an activity of promoting glucose absorption in muscle cells, and the whole animal tests show that the present compounds have effects on improving glucose-tolerance and insulin-resistance, facilitating weight loss, relieving fatty liver and the like. Thus, the present compounds can be used in treating diabetes mellitus, adiposity, fatty liver and complications thereof induced by insulin resistance.
Method and composition for controlling oral pathogens
申请人:Wu D. Christine
公开号:US20070098649A1
公开(公告)日:2007-05-03
A composition and method of controlling oral and other human pathogens is disclosed. The composition and method utilize an antimicrobial or antibiotic and a berberine as active agents to treat mammals, including humans.
Structure-activity relationships of quaternary protoberberine alkaloids having an antimalarial activity
作者:Kinuko Iwasa、Yumi Nishiyama、Momoyo Ichimaru、Masataka Moriyasu、Hye-Sook Kim、Yusuke Wataya、Takao Yamori、Turuo Takashi、Dong-Ung Lee
DOI:10.1016/s0223-5234(99)00127-0
日期:1999.12
Seventeen quaternary protoberberine alkaloids related to berberine I were tested for antimalarial activity in vitro against Plasmodium falciparum and structure-activity relationships are proposed. The activity of the protoberberine alkaloids was influenced by the type of the oxygen substituents on rings A, C and D and the position of the oxygen functions on ring D. The position of the oxygen functions on ring D and the type of the oxygen substituents at the C-13 position (ring C) strongly influenced the activity. Shifting the oxygen functions at C-9 and C-10 to C-10 and C-Il on ring D resulted in a significant increase in the activity. Compounds bearing a methylenedioxy function at C-2 and C-3 (ring A) or C-9 and C-IO (ring D) showed higher activity than those which have methoxy groups at the same positions. Introduction of a methoxy group into the C-l position (ring A) decreased the activity. Replacement of a hydroxy group at C-2 or C-3 (ring A) by a methoxy group led to a reduction in the activity. Displacement of a hydroxy function at C-13 (ring C) by the oxygen substituents such as OMe, Oft, OCOOEt, and OCON(Me)(2) reduced the activity. In the same replacement at C-9 (ring D), the activity depended upon the type of the oxygen function. Six protoberberines displayed more potent activity than berberine 1. The activity decreased in the order: 10, 11, 17 and 18 > 7 and 8 > 1. (C) 1999 Editions scientifiques et medicales Elsevier SAS.